secwatch.observer — SEC 8-K summary
======================================

Issuer:     Spectral AI, Inc. (MDAI)
CIK:        0001833498
Form:       8-K
Filed at:   2025-04-02T23:59:59+00:00
Accession:  0001213900-25-027531
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Spectral AI reports FY2024 R&D revenue $29.6M; net loss $(15.3)M; plans FDA submission by Q2 2025
--------------------------------------------------------------------------------

- FY2024 R&D revenue $29.6M (+63.5% YoY); net loss $(15.3)M ($(0.85)/share) vs $(20.9)M in FY2023.
- Burn Validation Study: DeepView sensitivity 86.6% (image-wise) vs 40.8% for burn physicians; FDA De Novo submission planned by Q2 2025.
- Cash $5.2M at Dec 31, 2024; raised $11.2M in Q1 2025 via $8.5M debt & $2.7M equity; FY2025 revenue guidance ~$21.5M.
- CFO Vincent Capone amended employment: base salary $440k, bonus up to $250k; 100k RSUs vested, 75k stock options granted.
- Spin-off of Spectral IP into public company expected by end of Q2 2025; warrants repriced from $11.50 to $2.75.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1833498/000121390025027531/0001213900-25-027531-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1833498/000121390025027531/ea0236475-8k_spectral.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-027531

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer